We have located links that may give you full text access.
Clinical Trial
Journal Article
Randomized Controlled Trial
Does the type of arthroscopic surgery modify the analgesic effect of intraarticular morphine and bupivacaine? A preliminary study.
Clinical Journal of Pain 2003 July
OBJECTIVE: To analyze the different analgesic response to intraarticular morphine and bupivacaine in different types of arthroscopic surgery.
DESIGN: Prospective, randomized and double-blinded. Fifty-three consecutive patients undergoing an arthroscopic knee procedure under general anesthesia. They were studied separately in 2 groups (types of surgery): (1) "Low inflammatory surgery": diagnostic arthroscopy, partial meniscectomy; and (2) "High inflammatory surgery": ACL (anterior cruciate ligament) reconstruction, lateral release, patellar shaving and plicae removal. At the end of the procedure, patients were randomized to receive 25 mL of bupivacaine 0.25% with epinephrine (1/200,000), 5 mg of morphine, or saline (placebo) into the knee joint. Postoperative pain was determined through the visual analog scale (VAS). Supplemental analgesia (ketorolac) was administered via intravenous patient-controlled analgesia (i.v. PCA). Pain and requirements of analgesia were compared between bupivacaine, morphine, and placebo in each group of surgery.
RESULTS: When considering only the "Low inflammatory" group of patients, those who received bupivacaine showed a lower postoperative pain score at 4 and 8 hours (P < 0.05). When considering only the "High inflammatory" group, the patients who received morphine showed a lower postoperative pain score at 24 hours and less requirements of ketorolac (P < 0.05).
CONCLUSIONS: The analgesic effect of morphine and bupivacaine is different depending on the type of arthroscopic surgery. Intraarticular bupivacaine is effective in surgeries with a low inflammatory response. For surgeries with a higher inflammatory response, morphine has a better analgesic effect. Postoperative intraarticular analgesic therapy should be indicated according to the performed arthroscopic procedure.
DESIGN: Prospective, randomized and double-blinded. Fifty-three consecutive patients undergoing an arthroscopic knee procedure under general anesthesia. They were studied separately in 2 groups (types of surgery): (1) "Low inflammatory surgery": diagnostic arthroscopy, partial meniscectomy; and (2) "High inflammatory surgery": ACL (anterior cruciate ligament) reconstruction, lateral release, patellar shaving and plicae removal. At the end of the procedure, patients were randomized to receive 25 mL of bupivacaine 0.25% with epinephrine (1/200,000), 5 mg of morphine, or saline (placebo) into the knee joint. Postoperative pain was determined through the visual analog scale (VAS). Supplemental analgesia (ketorolac) was administered via intravenous patient-controlled analgesia (i.v. PCA). Pain and requirements of analgesia were compared between bupivacaine, morphine, and placebo in each group of surgery.
RESULTS: When considering only the "Low inflammatory" group of patients, those who received bupivacaine showed a lower postoperative pain score at 4 and 8 hours (P < 0.05). When considering only the "High inflammatory" group, the patients who received morphine showed a lower postoperative pain score at 24 hours and less requirements of ketorolac (P < 0.05).
CONCLUSIONS: The analgesic effect of morphine and bupivacaine is different depending on the type of arthroscopic surgery. Intraarticular bupivacaine is effective in surgeries with a low inflammatory response. For surgeries with a higher inflammatory response, morphine has a better analgesic effect. Postoperative intraarticular analgesic therapy should be indicated according to the performed arthroscopic procedure.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app